• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核苷酸-88(C-T)启动子突变是印度旁遮普邦贾特锡克人中常见的β地中海贫血突变。

Nucleotide -88 (C-T) promoter mutation is a common beta-thalassemia mutation in the Jat Sikhs of Punjab, India.

作者信息

Garewal Gurjeewan, Das Reena, Ahluwalia Jasmina, Marwaha R K, Varma S

机构信息

Department of Haematology, Postgraduate Institute of Medical Education & Research, Chandigarh, India.

出版信息

Am J Hematol. 2005 Aug;79(4):252-6. doi: 10.1002/ajh.20445.

DOI:10.1002/ajh.20445
PMID:16044458
Abstract

A study of beta-gene mutations in Jat Sikhs, a subcaste of Punjabis, revealed a very high prevalence (46%: 41/88) of the mild beta++ promoter region mutation -88 (C-T). Sixteen individuals presenting in homozygous form were clinically mild. Un-transfused patients had characteristic hematological findings: high Hb F (38.1-68.6%, mean 47.4%), high Hb A2 (5.7-9.8%, mean 6.88%), and the rest had adult hemoglobin. The 19 subjects with compound heterozygosity for -88 (C-T) and another beta-gene mutation presented both as thalassemia intermedia (four cases) and as thalassemia major (15 cases). One of the four patients with the milder phenotype had a second mild mutation, CAP+1 (beta++). In the other three cases with the milder phenotype, the second mutation was associated with the presence of the XmnI Ggamma polymorphism. Notably, the XmnI Ggamma was negative in all the -88 (C-T) alleles. None of the patients had associated alpha-thalassemia even in the thalassemia intermedia group. Haplotype analysis of the -88 (C-T) homozygous cases showed a single haplotype (+ - - - - + -) in all but two individuals. This haplotype is distinct from those described in the Africans with homozygous -88 (C-T), suggesting that the mutation in our population occurred independently.

摘要

一项针对旁遮普人一个亚种贾特锡克人的β基因突变研究显示,轻度β++启动子区域-88(C-T)突变的患病率非常高(46%:41/88)。16名呈纯合形式的个体临床症状较轻。未输血的患者有典型的血液学表现:高Hb F(38.1 - 68.6%,平均47.4%)、高Hb A2(5.7 - 9.8%,平均6.88%),其余患者为成人血红蛋白。19名-88(C-T)与另一种β基因突变的复合杂合子受试者表现为中间型地中海贫血(4例)和重型地中海贫血(15例)。4例表型较轻的患者中有1例有第二个轻度突变,即CAP +1(β++)。在其他3例表型较轻的病例中,第二个突变与XmnI Gγ多态性的存在有关。值得注意的是,所有-88(C-T)等位基因中的XmnI Gγ均为阴性。即使在中间型地中海贫血组中,也没有患者伴有α地中海贫血。-88(C-T)纯合病例的单倍型分析显示,除2名个体外,所有个体均为单一单倍型(+ - - - - + -)。该单倍型与非洲纯合-88(C-T)个体中描述的单倍型不同,表明我们人群中的突变是独立发生的。

相似文献

1
Nucleotide -88 (C-T) promoter mutation is a common beta-thalassemia mutation in the Jat Sikhs of Punjab, India.核苷酸-88(C-T)启动子突变是印度旁遮普邦贾特锡克人中常见的β地中海贫血突变。
Am J Hematol. 2005 Aug;79(4):252-6. doi: 10.1002/ajh.20445.
2
Mutational spectrum of delta-globin gene in the Portuguese population.葡萄牙人群中δ-珠蛋白基因的突变谱。
Eur J Haematol. 2007 Nov;79(5):422-8. doi: 10.1111/j.1600-0609.2007.00949.x. Epub 2007 Oct 4.
3
Haplotypes linked to three rare beta-thalassemia mutations, originally reported in Tunisia.与三种罕见的β地中海贫血突变相关的单倍型,最初在突尼斯报道。
Hemoglobin. 2006;30(2):175-81. doi: 10.1080/03630260600642427.
4
A novel mutation of -73(A-->T) in the CCAAT box of the beta-globin gene identified in a patient with the mild beta-thalassemia intermedia.在一位患有轻度中间型β地中海贫血的患者中,发现β珠蛋白基因CCAAT盒存在一种新的-73(A→T)突变。
Ann Hematol. 2007 Sep;86(9):653-7. doi: 10.1007/s00277-007-0312-8. Epub 2007 May 22.
5
Impact of beta globin gene mutations on the clinical phenotype of beta thalassemia in India.β珠蛋白基因突变对印度β地中海贫血临床表型的影响。
Blood Cells Mol Dis. 2004 Sep-Oct;33(2):153-7. doi: 10.1016/j.bcmd.2004.05.002.
6
The clinical significance of the spectrum of interactions of CAP+1 (A-->C), a silent beta-globin gene mutation, with other beta-thalassemia mutations and globin gene modifiers in north Indians.北印度人中沉默型β-珠蛋白基因突变CAP+1(A→C)与其他β-地中海贫血突变及珠蛋白基因修饰因子相互作用谱的临床意义
Eur J Haematol. 2007 Nov;79(5):417-21. doi: 10.1111/j.1600-0609.2007.00958.x. Epub 2007 Sep 27.
7
Multicenter study of the molecular basis of thalassemia intermedia in different ethnic populations.不同种族人群中间型地中海贫血分子基础的多中心研究。
Hemoglobin. 2007;31(4):439-52. doi: 10.1080/03630260701641245.
8
Homozygosity for a rare beta 0-thalassemia mutation [frameshift codons 25/26 (+T)] causes beta-thalassemia intermedia in an Iranian family.一种罕见的β⁰地中海贫血突变(移码密码子25/26[+T])的纯合性在一个伊朗家庭中导致了中间型β地中海贫血。
Hemoglobin. 2009;33(1):75-80. doi: 10.1080/03630260802683377.
9
Asymptomatic and mild beta-thalassemia in homozygotes and compound heterozygotes for the IVS2+1G-->A mutation: role of the beta-globin gene haplotype.IVS2+1G→A突变纯合子和复合杂合子中的无症状及轻度β地中海贫血:β珠蛋白基因单倍型的作用
Haematologica. 2003 Oct;88(10):1099-105.
10
Spectrum of beta-thalassemia mutations and their association with allelic sequence polymorphisms at the beta-globin gene cluster in an Eastern Indian population.印度东部人群中β地中海贫血突变谱及其与β珠蛋白基因簇等位基因序列多态性的关联。
Am J Hematol. 2002 Aug;70(4):269-77. doi: 10.1002/ajh.10117.

引用本文的文献

1
Mutation Analysis of Exon 1 in the Hemoglobin Subunit Beta (HBB) Gene in Beta-Thalassemia.β地中海贫血中血红蛋白β亚基(HBB)基因第1外显子的突变分析
Cureus. 2024 Jul 23;16(7):e65198. doi: 10.7759/cureus.65198. eCollection 2024 Jul.
2
Extreme Genotype/Phenotype Heterogeneity of Double Heterozygous Sickle β-Thalassemia in a Family: Implications in Antenatal Diagnosis.一个家族中双杂合子镰状β地中海贫血的极端基因型/表型异质性:对产前诊断的启示
Indian J Hematol Blood Transfus. 2021 Oct;37(4):689-691. doi: 10.1007/s12288-021-01412-1. Epub 2021 Mar 4.
3
Sickle Cell Disease in Central India: A Potentially Severe Syndrome.
印度中部的镰状细胞病:一种潜在的严重综合征。
Indian J Pediatr. 2016 Oct;83(10):1071-6. doi: 10.1007/s12098-016-2081-7. Epub 2016 Apr 7.
4
Genetic Heterogeneity of Beta Globin Mutations among Asian-Indians and Importance in Genetic Counselling and Diagnosis.亚洲印第安人β珠蛋白基因突变的遗传异质性及其在遗传咨询和诊断中的重要性。
Mediterr J Hematol Infect Dis. 2013;5(1):e2013003. doi: 10.4084/MJHID.2013.003. Epub 2013 Jan 2.
5
A descriptive profile of β-thalassaemia mutations in India, Pakistan and Sri Lanka.印度、巴基斯坦和斯里兰卡β地中海贫血突变的描述性概况。
J Community Genet. 2010 Sep;1(3):149-57. doi: 10.1007/s12687-010-0026-9. Epub 2010 Oct 10.
6
Past, present & future scenario of thalassaemic care & control in India.印度地中海贫血症防治的过去、现在和未来情景。
Indian J Med Res. 2011 Oct;134(4):507-21.
7
Mutational spectrum of thalassemias in India.印度地中海贫血的突变谱。
Indian J Hum Genet. 2007 Jan;13(1):36-7. doi: 10.4103/0971-6866.32034.
8
Profiling β-thalassaemia mutations in India at state and regional levels: implications for genetic education, screening and counselling programmes.印度各邦及地区β地中海贫血基因突变分析:对遗传教育、筛查及咨询项目的启示
Hugo J. 2009 Dec;3(1-4):51-62. doi: 10.1007/s11568-010-9132-3. Epub 2010 Feb 10.